Auspex Pharmaceuticals Inc

Founded: 
2007
Industry: 
2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products
Address: 
Auspex Pharmaceuticals Inc
1261 Liberty Way Suite C
92081-8356 Vista , California
United States
Phone: (760) 599-1800
See map: Google Maps
California US
Auspex Pharmaceuticals Inc
3366 N Torrey Pines Court Suite 225
92037 La Jolla , California
United States
Phone: (858) 558-2400
See map: Google Maps
California US
Registration country: 
United States
ISIC Code: 
2100
CIK: 
0001454189
0001454189
Overview: 

Web site: 
http://www.auspexpharma.com

Add business model

Funding history

Series C

(Oct 2010)
Investor Profile Country Industry Notes
CMEA Capital
(CMEA Ventures), (Chemical and Materials Enterprise Associates)
 		United States 6630 Fund management edit
Sloan Ventures LLC
 		United States edit
Thomas McNerney & Partners LLC
 		Healthcare venture firm. United States 6630 Fund management edit

Add participant

Series B

(May 2008)
Investor Profile Country Industry Notes
CMEA Capital
(CMEA Ventures), (Chemical and Materials Enterprise Associates)
 		United States 6630 Fund management edit
Thomas McNerney & Partners LLC
 		Healthcare venture firm. United States 6630 Fund management edit

Add participant

Add a funding round or a fund closing.

Cap table (beta)

Add an employee

SEC Filings

6 Sep 2013 Form D/A
Industry group:
  • Health Care
  • Pharmaceuticals
Date of first sale: 31 Oct 2012
Offering amount: USD 27,992,742
Amount sold: USD 27,992,742
Number of investors: 9
Remaining to be sold: USD 0
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0
9 Nov 2012 Form D
Industry group:
  • Health Care
  • Pharmaceuticals
Date of first sale: 31 Oct 2012
Offering amount: USD 25,492,741
Amount sold: USD 17,492,739
Number of investors: 8
Remaining to be sold: USD 8,000,002
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0
31 Jul 2012 Form D
Industry group:
  • Health Care
  • Pharmaceuticals
Date of first sale: 18 Jul 2012
Offering amount: USD 3,000,000
Amount sold: USD 1,500,000
Number of investors: 5
Remaining to be sold: USD 1,500,000
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0

Warrants for the purchase of Preferred Stock were issued in connection with the Offering for no additional consideration. The aggregate number of warrant shares is contingent on a formula set forth in each of the warrants.

28 Dec 2011 Form D
Industry group:
  • Health Care
  • Pharmaceuticals
Date of first sale: 15 Dec 2011
Offering amount: USD 6,000,000
Amount sold: USD 3,000,000
Number of investors: 7
Remaining to be sold: USD 3,000,000
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0

Warrants for the purchase of Pref Stock were issued at the Offering. No additional consideration was received for the Warrants. The # of warrant shares issuable upon exercise of the Warrants is contingent upon a formula set forth in each of the Warrants.

26 Jul 2010 Form D
Industry group:
  • Health Care
  • Pharmaceuticals
Date of first sale: 15 Jun 2007
Offering amount: USD 13,825,000
Amount sold: USD 13,825,000
Number of investors: 5
Remaining to be sold: USD 0
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0
12 Jul 2010 Form D
Industry group:
  • Health Care
  • Pharmaceuticals
Date of first sale: 2 Jul 2010
Offering amount: USD 11,999,999
Amount sold: USD 11,999,999
Number of investors: 8
Remaining to be sold: USD 0
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0
26 Feb 2010 Form D
Industry group:
  • Health Care
  • Pharmaceuticals
Date of first sale: 8 Jan 2010
Offering amount: USD 2,000,000
Amount sold: USD 2,000,000
Number of investors: 6
Remaining to be sold: USD 0
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0

No additional consideration was received for the issuance of the warrants. The aggregate number of warrant shares issuable upon exercise of the warrants is contingent upon a formula set forth in each of the warrants.

22 Oct 2009 Form D
Industry group:
  • Health Care
  • Pharmaceuticals
Date of first sale: 9 Oct 2009
Offering amount: USD 2,000,000
Amount sold: USD 2,000,000
Number of investors: 5
Remaining to be sold: USD 0
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0

No additional consideration was received for the issuance of the warrants. The aggregate number of warrant shares issuable upon exercise of the warrants is contingent upon a formula set forth in each of the warrants.

3 Aug 2009 Form D
Industry group:
  • Health Care
  • Pharmaceuticals
Date of first sale: 22 May 2009
Offering amount: USD 3,000,000
Amount sold: USD 3,000,000
Number of investors: 7
Remaining to be sold: USD 0
Minimum investment accepted: USD 0
Sales commissions: USD 0
Finders' fees: USD 0
Use of proceeds: USD 0

Add Form D

Insights: 
Patent search (Google)
PSEPS ID: 448818
External Links